Sword Health, which provides digital physical therapy, raises a $163M Series D at a $2B valuation led by Sapphire Ventures
Michelle F Davis / Bloomberg :
Context & Ripple Effects
Sword Health's $163M Series D lands three weeks after rival Hinge Health raised $400M at a $6.2B valuation — double Sword's new $2B mark — confirming that employer-focused digital musculoskeletal care had become the hottest category in health tech funding that quarter. Sapphire Ventures leading the round also fits its late-stage push, with the firm closing a new $1B fund for growth-stage startups.
The arc since then has validated both bets: Sword went on to raise $130M at a $3B valuation in June 2024 and another round at $4B in 2025, while Hinge Health took the category public with a $437M IPO in May 2025.
First-order effects
- Sword Health gets the balance sheet to scale its virtual physical therapy offering against Hinge Health, whose valuation lead of more than 3x sets the benchmark every subsequent Sword round is measured against.
- Sapphire Ventures deploys its newly raised late-stage fund into one of the period's most competitive categories, taking a lead position ahead of the sector's eventual public-market exits.
Second-order effects
- Hinge Health's funding head start pressures Sword to keep raising at step-up valuations — which it did through 2024 and 2025 — and ultimately to buy rather than build, culminating in the $285M acquisition of rival Kaia Health.
- Employers and health plans buying digital MSK care gain a genuine two-horse market, with pricing and outcome guarantees becoming the differentiator as both players chase the same self-insured customers.
Third-order effects
- The pattern points toward consolidation of digital physical therapy around a few scaled platforms — Hinge via IPO, Sword via rollup — squeezing out sub-scale rivals like Kaia that could not independently match the leaders' funding velocity.
- If the category keeps maturing from venture darling to public company, the next battleground shifts from fundraising to proving clinical outcomes and retention at public-market scrutiny levels.
The trend: Digital musculoskeletal care is consolidating from a land-grab of parallel mega-rounds into a two-platform market shaped by public-market exits and acquisitions.